ReviewBMC complementary and alternative medicine2016
Perception of risk and communication among conventional and complementary health care providers involving cancer patients' use of complementary therapies: a literature review.
Review in BMC complementary and alternative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Physicians' Knowledge and Experiences of Counseling on Complementary, Alternative, and Integrative Medicine in Cancer Care: a Qualitative Systematic Review.Current oncology reports · 2026Pooled it
- Communication Between Cancer Patients and Physicians About Complementary and Alternative Medicine: A Systematic Review.Journal of integrative and complementary medicine · 2023Pooled it
- An integrative review on the information and communication needs of parents of children with cancer regarding the use of complementary and alternative medicine.BMC complementary medicine and therapies · 2020Pooled it
- Mistletoe in oncological treatment: a systematic review : Part 2: quality of life and toxicity of cancer treatment.Journal of cancer research and clinical oncology · 2019Pooled it
- Vitamin/mineral and non-vitamin/non-mineral supplement use of breast cancer survivors in Korea.Nutrition research and practice · 2026Article
- Investigating complementary and alternative medicine in Norwegian hospitals: a cross-sectional study with process evaluation.BMC complementary medicine and therapies · 2026Article
- "At least i am doing something": a health belief model-guided qualitative study of nutritional supplement use among cancer patients during treatment.Frontiers in nutrition · 2026Article
- Communication between Norwegian Pakistani patients and healthcare providers about traditional and complementary medicine: a qualitative study.International journal of qualitative studies on health and well-being · 2025Article
- Complementary therapies in early breast cancer: Oncologists' evidence-based decisions in a Southeast European vignette survey.Biomolecules & biomedicine · 2025Article
- Barriers to communication about complementary and alternative medicine between oncology patients and healthcare professionals in Croatia: a cross-sectional study.Korean journal of medical education · 2025Article
- Goutweed (Molecules (Basel, Switzerland) · 2025Review
- Education about complementary and alternative medicine in cancer self-help groups by trained peers.BMC complementary medicine and therapies · 2024Observational
- Use and perception of risk: traditional medicines of Pakistani immigrants in Norway.BMC complementary medicine and therapies · 2024Article
- Oncology researchers' and clinicians' perceptions of complementary, alternative, and integrative medicine: an international, cross-sectional survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- Article
- A review of the WHO strategy on traditional, complementary, and integrative medicine from the perspective of academic consortia for integrative medicine and health.Frontiers in medicine · 2024Review
- Cancer patients' behaviors and attitudes toward natural health products.BMC complementary medicine and therapies · 2023Article
- Complementary and alternative medicine in oncology: knowledge, attitude and practice among Tunisian healthcare workers.Journal of cancer research and clinical oncology · 2023Article
- Use of CAM among cancer patients : Results of a regional survey in Sweden.BMC complementary medicine and therapies · 2023Article
- Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway.BMC complementary medicine and therapies · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCommunication between different health care providers (conventional and complementary) and cancer patients about their use of complementary therapies affects the health and safety of the patients. The aim of this study was to examine the qualitative research literature on the perception of and communication about the risk of complementary therapies between different health care providers and cancer patients.
methodsSystematic searches in six medical databases covering literature from 2000 to 2015 were performed. The studies were accessed according to the level of evidence and summarized into different risk situations. Qualitative content analysis was used to analyze the text data, and the codes were defined before and during the data analysis.
resultsTwenty-nine papers were included in the primary analysis and five main themes were identified and discussed. The main risk situations identified were 1. Differences in treatment concepts and philosophical values among complementary and conventional health care providers. 2. Adverse effects from complementary products and herbs due to their contamination/toxicity and interactions with conventional cancer treatment. 3. Health care physicians and oncologists find it difficult to recommend many complementary modalities due to the lack of scientific evidence for their effect. 4. Lack of knowledge and information about complementary and conventional cancer treatments among different health care providers.
conclusionThe risk of consuming herbs and products containing high level of toxins is a considerable threat to patient safety (direct risk). At the same time, the lack of scientific evidence of effect for many complementary therapies and differences in treatment philosophy among complementary and conventional health care providers potentially hinder effective communication about these threats with mutual patients (indirect risk). As such, indirect risk may pose an additional risk to patients who want to combine complementary therapies with conventional treatment in cancer care. Health care providers who care for cancer patients should be aware of these risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.